论文部分内容阅读
目的:观察口服米索前列醇治疗产后宫腔积血的效果。方法:将2007-01/2007-12收治的256例宫腔积血产妇随机分为观察组与对照组,观察组予以米索前列醇口服,对照组给予缩宫素10 U肌内注射。结果:观察组的子宫复旧明显好于对照组,两组超声下测量宫腔缩小程度差异有统计学意义(P<0.005),两组患者治疗后有效率分别为91.17%、78.33%,口服米索前列醇的患者宫腔持续积血明显减少,有效降低了清宫术的应用。结论:米索前列醇治疗产后宫腔积血效果显著,用药方便,值得推广。
Objective: To observe the effect of oral misoprostol on postpartum uterine hemorrhage. Methods: A total of 256 cases of uterine hemorrhage from January 2007 to December 2007 were randomly divided into observation group and control group. The observation group was given misoprostol orally, while the control group was given intrauterine injection of oxytocin 10 U. Results: The uterine involution in the observation group was significantly better than that in the control group. There was significant difference in the reduction of uterine cavity between the two groups (P <0.005). The effective rates of the two groups after treatment were 91.17% and 78.33%, respectively Supramoetine patients with continuous reduction of uterine bleeding, effectively reducing the application of curettage. Conclusion: Misoprostol treatment of postpartum uterine hemorrhage significant effect, convenient medication, it is worth promoting.